Dr Andrea Wilson of Edith Cowan University and the DCRC – Early Diagnosis and Prevention has completed a literature review of the use of biomarkers for Alzheimer's disease.
The very interesting findings from the research include:
- The use of using CSF biomarkers in AD risk reduction, diagnosis and research is more important than ever
- There are risks associated with the collection of CSF However, it has been found that clinical quality control measures can mitigate these risks
- This research has implications for future research and knowledge translation
Andrea’s comprehensive report written non-technically for Dementia Research News is available here: “Cerebral Spinal Fluid Biomarkers for use in Alzheimer’s Disease Research Collection"
Other stories from this edition of Dementia Research News:
Director's report and welcome from Prof Elizabeth Beattie
Examining the use of the Aged Care Funding Instrument (ACFI)
The use of biomarkers for Alzheimer's disease
Pain and Pain Management for RACF and Community Settings
News in brief:
Diagnosing mild cognitive impairment in linguistic minorities
Scholarship opportunity with the DCRC
Managing Depression Growing Older
